Literature DB >> 7793135

Influenza immunization for HIV-infected persons in Los Angeles.

F J Sorvillo1, B L Nahlen.   

Abstract

We assessed the use of influenza vaccine in a cohort of HIV-infected patients during 1991 and 1992 in Los Angeles County. Influenza vaccination status and clinical and demographic data were obtained from medical records in three different outpatient clinics: a health maintenance organization (HMO), a public clinic and a private medical group. The overall proportion of patients immunized with influenza vaccine was 28%. Patients receiving medical care at the HMO were more likely to receive influenza vaccine (45%) than were patients at the public clinic (25%) or the private facility (13%). Higher immunization levels were also observed among patients with greater numbers of clinic visits for both years studied (p < 0.001). After we controlled for the number of outpatient visits, patients at the HMO and the public clinic were still more likely to receive influenza vaccine in both 1991 (adjusted relative risks 3.2 and 2.1, respectively) and 1992 (adjusted relative risks 1.7 and 1.8) compared with private clinic patients. Health-care providers should increase efforts to provide influenza vaccine to HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793135     DOI: 10.1016/0264-410x(95)98261-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Authors:  Keri N Althoff; Kathryn Anastos; Kenrad E Nelson; David D Celentano; Gerald B Sharp; Ruth M Greenblatt; Audrey L French; Don J Diamond; Susan Holman; Mary Young; Stephen J Gange
Journal:  Prev Med       Date:  2010-03-18       Impact factor: 4.018

2.  Assessing influenza vaccination coverage and predictors in persons living with HIV/AIDS in Louisiana, June 2002-June 2013.

Authors:  Patrick Maloney; Ariane Rung; Stephanie Broyles; John Couk; Edward Peters; Susanne Straif-Bourgeois
Journal:  J Prev Med Hyg       Date:  2022-04-26

3.  Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Authors:  P Durando; D Fenoglio; A Boschini; F Ansaldi; G Icardi; L Sticchi; A Renzoni; P Fabbri; A Ferrera; A Parodi; B Bruzzone; G Gabutti; A Podda; G Del Giudice; E Fragapane; F Indiveri; P Crovari; R Gasparini
Journal:  Clin Vaccine Immunol       Date:  2007-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.